Azoospermia
Obstructive vs Non-Obstructive Absence of Sperm
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Diagnostic category; treatments range from microsurgery to assisted reproduction
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about azoospermia in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Azoospermia is the complete absence of sperm in the ejaculate, confirmed on at least two centrifuged samples. It is found in roughly 1% of all men and 10-20% of men presenting to infertility clinics. The central distinction is obstructive azoospermia (normal sperm production blocked from exiting) versus non-obstructive azoospermia (impaired or absent production), which together determine prognosis and whether surgical sperm retrieval can succeed.
No sperm in the ejaculate does not always mean no sperm in the testis.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Workup combines hormonal testing (FSH, testosterone), physical exam (vas deferens presence, testicular volume), and often genetics (karyotype, Y-chromosome microdeletions, CFTR for suspected congenital absence of the vas deferens). Obstructive azoospermia features normal testicular volume and FSH with normal spermatogenesis blocked downstream, and is often correctable by microsurgical reconstruction or treatable by epididymal/testicular sperm aspiration. Non-obstructive azoospermia reflects testicular failure, frequently with elevated FSH and small testes, where microdissection testicular sperm extraction (micro-TESE) searches the testis for focal pockets of sperm production.
Why retrieval odds vary so widely
In non-obstructive azoospermia, success depends heavily on the underlying cause. Reported micro-TESE retrieval rates differ markedly by etiology, with higher rates described after prior orchitis or cryptorchidism and lower rates in idiopathic cases. Micro-TESE under the operating microscope roughly doubles retrieval odds compared with conventional TESE in several series. Even when sperm are found, fertilization requires ICSI and outcomes remain partner- and cohort-dependent.
Safety in detail
- Surgical sperm retrieval carries risks of bleeding, infection, and potential decline in testicular function.
- Genetic causes (Y-microdeletions, Klinefelter syndrome) may be heritable and warrant counseling.
- FSH and testicular volume guide but do not perfectly predict retrieval success.
What it does to fertility
Azoospermia is, by definition, a fertility-defining diagnosis. Importantly, exogenous testosterone and anabolic steroids can cause iatrogenic azoospermia by suppressing the hypothalamic-pituitary-gonadal axis and intratesticular testosterone; this is frequently reversible after cessation, sometimes aided by hCG or selective estrogen receptor modulators under specialist care.
What people get wrong
Often saidNo sperm in the ejaculate means no biological fatherhood is possible
ActuallyMany men with azoospermia have retrievable testicular or epididymal sperm usable with ICSI, especially in obstructive cases.
Often saidAzoospermia is always permanent
ActuallyObstructive causes such as post-vasectomy blockage are often reversible by microsurgery, and some non-obstructive cases yield sperm on micro-TESE.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
The obstructive/non-obstructive framework crystallized in the 1990s as microsurgical reconstruction and, later, ICSI (introduced 1992) transformed prognosis. Schlegel's 1999 description of micro-TESE made testicular sperm retrieval far more systematic, shifting many men from 'sterile' to potentially fertile through assisted reproduction.
- 1992ICSI enables fertilization with very few sperm
- 1999Microdissection TESE described, improving retrieval in non-obstructive azoospermia
What we do not know
- Can biomarkers predict micro-TESE success before surgery?
- What is the optimal hormonal optimization before retrieval?
At a glance
- Population prevalence
- ~1% of men
- Among infertility patients
- 10-20%
- Non-obstructive share of azoospermia
- ~60%
- Micro-TESE retrieval (meta-analysis)
- ~46% overall
- Confirmation
- 2 centrifuged samples
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Azoospermia. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Schlegel, microdissection TESE technique1999
Introduced operating-microscope dissection that improved sperm retrieval over conventional biopsy in non-obstructive azoospermia
Comparative TESE seriesvarious
Microdissection TESE retrieval (~57%) reported significantly higher than conventional TESE (~38%)
EAU Guidelines on Sexual and Reproductive Healthongoing
Updated recommendations on indications and techniques for conventional and microdissection TESE in non-obstructive azoospermia